| dc.contributor.author | Findik G. | |
| dc.contributor.author | Aydin F. | |
| dc.contributor.author | Şentürk N. | |
| dc.contributor.author | Cantürk T. | |
| dc.contributor.author | Turanli A.Y. | |
| dc.date.accessioned | 2020-06-21T09:14:39Z | |
| dc.date.available | 2020-06-21T09:14:39Z | |
| dc.date.issued | 2003 | |
| dc.identifier.issn | 1300-2996 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12712/2445 | |
| dc.description.abstract | The importance of immune system in pathogenesis of psoriasis have led to development of new therapeutic agents that selectively act on receptors, chemokines and cytokines to immune system. This article reviews recent developments in immune based therapies for psoriasis. | en_US |
| dc.language.iso | tur | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.subject | Biologic therapy | en_US |
| dc.subject | Immune system | en_US |
| dc.subject | Psoriasis | en_US |
| dc.title | Biological treatment agents in the psoriasis | en_US |
| dc.title.alternative | Psoriasis tedavisinde biyolojik ajanlar | en_US |
| dc.type | review | en_US |
| dc.contributor.department | OMÜ | en_US |
| dc.identifier.volume | 20 | en_US |
| dc.identifier.issue | 4 | en_US |
| dc.identifier.startpage | 211 | en_US |
| dc.identifier.endpage | 216 | en_US |
| dc.relation.journal | Ondokuz Mayis Universitesi Tip Dergisi | en_US |
| dc.relation.publicationcategory | Diğer | en_US |
